Positive 6 Month Results from CroíValve’s TANDEM I Study to Treat Tricuspid Regurgitation Presented at New York Valves 2024
Favorable patient outcomes from the TANDEM I first-in-human clinical trial [...]
Favorable patient outcomes from the TANDEM I first-in-human clinical trial [...]